Herbas VPB

Print
EN | LT
LT - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR USE IN THE TREATMENT OF UVEITIS
EN - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR USE IN THE TREATMENT OF UVEITIS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/00
A61K 38/03
A61K 38/04
A61P 27/02
European patent
(11) Number of the document 2627346
(13) Kind of document T
(96) European patent application number 11775734.4
Date of filing the European patent application 2011-10-14
(97) Date of publication of the European application 2013-08-21
(45) Date of publication and mention of the grant of the patent 2016-03-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2011/005172
Date 2011-10-14
PCT application publication
(87) Number WO 2012/048893
Date 2012-04-19
Priority applications
(30) Number Date Country code
PCT/EP2011/0003 2011-01-25 WO
PCT/EP2010/0062 2010-10-14 WO
Inventors
(72)
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
ABADIE, Claire, FR
Grantee
(73) Xigen Inflammation Ltd., Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY
Title
(54) CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR USE IN THE TREATMENT OF UVEITIS
  CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR USE IN THE TREATMENT OF UVEITIS
Last update date 2021-04-30